STOCK TITAN

TELESCOPE INNOVATIONS CORP Stock Price, News & Analysis

TELIF OTC

Welcome to our dedicated page for TELESCOPE INNOVATIONS news (Ticker: TELIF), a resource for investors and traders seeking the latest updates and insights on TELESCOPE INNOVATIONS stock.

Telescope Innovations Corp. (OTCQB: TELIF) regularly issues news and updates that highlight its progress in intelligent automation, Self-Driving Labs, and advanced chemical manufacturing technologies. Company announcements describe deployments of Self-Driving Labs for pharmaceutical research and education, development milestones in lithium processing technologies, and commercial traction for products such as DirectInject-LC™.

News releases detail Telescope’s installation of a pharmaceutical Self-Driving Lab for the Korean Pharmaceutical and Biopharmaceutical Manufacturers Association in Seoul, which the company describes as Korea’s first Self-Driving Lab for pharmaceutical development and training. Other updates cover a multi-year, funded Self-Driving Lab development project with Pfizer and broader initiatives to expand SDL adoption across pharmaceuticals, industrial chemistry, energy, and agriculture.

Telescope’s news flow also includes information on its proprietary lithium technologies, including the ReCRFT™ process for producing battery-grade lithium carbonate from battery recycling brines and the DualPure™ process for low-temperature lithium sulfide production. The company reports government funding approvals to advance and scale these processes, as well as participation in the Arkansas Lithium Technology Accelerator to explore commercialization pathways with industry partners.

In addition, Telescope publishes updates on corporate developments such as stock option and restricted share unit grants, debt settlement transactions using common shares, and executive appointments that support its growth in online analytics and Self-Driving Lab deployments. Investors and followers of TELIF can use this news stream to monitor operational milestones, technology validation, partnerships, and capital markets activity described directly by the company.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.57%
Tags
partnership
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of TELESCOPE INNOVATIONS (TELIF)?

The current stock price of TELESCOPE INNOVATIONS (TELIF) is $0.2471 as of February 24, 2026.

What is the market cap of TELESCOPE INNOVATIONS (TELIF)?

The market cap of TELESCOPE INNOVATIONS (TELIF) is approximately 14.3M.

TELIF Rankings

TELIF Stock Data

14.25M
65.94M
Biotechnology
Healthcare
Link
Canada
Vancouver

TELIF RSS Feed